Luxturna & Crysvita Pioneer Scotland’s New Orphan HTA System

 
• By Francesca Bruce

Novartis’s Luxturna and Kyowa Kirin’s Crysvita are the first drugs to be evaluated through Scotland’s new ultra-orphan process.

Male red plastic toy businessman silhouette wooden figure background closeup. Manipulate work recruitment transfer labour inspectorate experience exchange man hr worker subordination human concept
Scotland Announces First Drugs To Undergo New Ultra Orphan Route

More from Europe

More from Geography